Zacks: Analysts Anticipate Senseonics Holdings, Inc. (NASDAQ:SENS) Will Post Earnings of -$0.16 Per Share

Equities research analysts expect that Senseonics Holdings, Inc. (NASDAQ:SENS) will report earnings per share of ($0.16) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Senseonics’ earnings. The highest EPS estimate is ($0.14) and the lowest is ($0.17). Senseonics also reported earnings of ($0.16) per share during the same quarter last year. The business is scheduled to report its next quarterly earnings report on Wednesday, August 14th.

According to Zacks, analysts expect that Senseonics will report full year earnings of ($0.65) per share for the current year, with EPS estimates ranging from ($0.67) to ($0.59). For the next financial year, analysts forecast that the company will report earnings of ($0.52) per share, with EPS estimates ranging from ($0.57) to ($0.45). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Senseonics.

Senseonics (NASDAQ:SENS) last announced its earnings results on Thursday, May 9th. The company reported ($0.17) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.05). The business had revenue of $3.42 million for the quarter, compared to analyst estimates of $4.05 million.

Shares of SENS traded down $0.03 during mid-day trading on Friday, reaching $2.01. The stock had a trading volume of 1,121,299 shares, compared to its average volume of 1,651,939. Senseonics has a 12 month low of $1.74 and a 12 month high of $5.29.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

See Also: What is intrinsic value?

Get a free copy of the Zacks research report on Senseonics (SENS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.